Loading...
Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
At present, the only approved inhaled antipseudomonal antibiotics for chronic pulmonary infections in patients with cystic fibrosis (CF) are nebulized solutions. However, prolonged administration and cleaning times, high administration frequency, and cumbersome delivery technologies with nebulizers...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Mary Ann Liebert, Inc.
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3146747/ https://ncbi.nlm.nih.gov/pubmed/21395432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2010.0855 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|